FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025

---
FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025
Vote:
0 0
Previous GAC debuted at the Auto Shanghai, unveiling the "X-SOUL AI Panorama" and four new models, accelerating the entry into the era of AI-powered vehicles
Next NYSE Content Advisory: Pre-Market update + Elon Musk to lessen time running DOGE

Related News

Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology

Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment

Late-Breaking Research - Alphamab Oncology Presents Preclinical Results of KN052 at AACR 2023

menu
menu